. 2022 Oct 6;36(11):108336. doi: 10.1016/j.jdiacomp.2022.108336

Table 1.

Increased risk of new-onset diabetes and new antidiabetic agent use in the VA study.³⁷

	Incident diabetes	Incident antihyperglycemic use	Both
Hazard ratio^a	1.4 1·36–1·44	1.85 1.78–1.92	1.46 1.43–1.50
Excess burden^a	13.46 12.11–14.84	12.35 11.36–13.38	18.03 16.59–19.51

With 95 % CI's.